Biohaven Pharmaceutical
BHVN
#3449
Rank
NZ$5.46 B
Marketcap
$53.51
Share price
-0.66%
Change (1 day)
-44.45%
Change (1 year)

Market capitalization of Biohaven Pharmaceutical (BHVN)

Market cap: NZ$5.46 Billion

As of March 2025 Biohaven Pharmaceutical has a market cap of NZ$5.46 Billion. This makes Biohaven Pharmaceutical the world's 3449th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Biohaven Pharmaceutical from 2017 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$5.46 B-16.92%
2024NZ$6.57 B21.05%
2023NZ$5.43 B264.41%
2022NZ$1.49 B-88.72%
2021NZ$13.21 B85.61%
2020NZ$7.12 B68.14%
2019NZ$4.23 B73.79%
2018NZ$2.43 B78.08%
2017NZ$1.36 B

End of Day market cap according to different sources

On Mar 5th, 2025 the market cap of Biohaven Pharmaceutical was reported to be:

NZ$5.49 Billion
by Nasdaq info icon info icon
NZ$5.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.98 B-81.99%๐Ÿ‡บ๐Ÿ‡ธ USA